Cargando…
Early adherence to antihypertensive drugs and long‐term cardiovascular mortality in the “real world”
Autor principal: | Salazar, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678652/ https://www.ncbi.nlm.nih.gov/pubmed/34254421 http://dx.doi.org/10.1111/jch.14319 |
Ejemplares similares
-
Laboratory testing and antihypertensive medication adherence following initial treatment of incident, uncomplicated hypertension: A real‐world data analysis
por: Beall, Reed F., et al.
Publicado: (2022) -
Clinical impact of medication adherence on 10‐year cardio‐cerebrovascular mortality in newly diagnosed hypertensive patients
por: Kim, Cho‐Long, et al.
Publicado: (2021) -
Determination of level of self‐reported adherence of antihypertensive drug(s) and its associated factors among patient with hypertension at a tertiary care center
por: Bhusal, Laxman, et al.
Publicado: (2022) -
Impact of medication adherence on the efficacy of Baroreflex activation therapy
por: Schäfer, Ann‐Kathrin C., et al.
Publicado: (2022) -
Factors Associated With Nonadherence to Cardiovascular Medications: A Cross-sectional Study
por: van der Laan, Danielle M., et al.
Publicado: (2019)